Madhuri M Sopirala1. 1. Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center VA North Texas Healthcare System, Dallas, Texas, USA.
Abstract
PURPOSE OF REVIEW: There likely are several predisposing factors to secondary infections in patients with Coronavirus disease 2019 (COVID-19), some of which may be preventable. The aim of this review is to explore the literature, summarize potential predisposing factors to secondary infections and their incidence. It also summarizes a variety of healthcare scenarios in which different kinds of secondary infections occur. RECENT FINDINGS: Apart from immune dysregulation, severe resource limitations in healthcare settings have made COVID-19 units conducive to a variety of secondary infections. Long-term effect of excess antibiotic use in COVID-19 patients is yet to be studied. Very few studies have assessed secondary infections as the primary outcome measure making it difficult to know the true incidence. Mortality attributable to secondary infections in COVID-19 patients is also unclear. SUMMARY: Incidence of secondary infections in COVID-19 patients is likely higher than what is reported in the literature. Well designed studies are needed to understand the incidence and impact of secondary infections in this patient population. Many of these may be preventable especially now, as personal protective equipment and other healthcare resources are recovering. Infection prevention and control (IPC) and antimicrobial stewardship programmes (ASP) must reassess current situation to correct any breaches that could potentially cause more harm in these already vulnerable patients as we brace for a future surge with another pandemic wave.
PURPOSE OF REVIEW: There likely are several predisposing factors to secondary infections in patients with Coronavirus disease 2019 (COVID-19), some of which may be preventable. The aim of this review is to explore the literature, summarize potential predisposing factors to secondary infections and their incidence. It also summarizes a variety of healthcare scenarios in which different kinds of secondary infections occur. RECENT FINDINGS: Apart from immune dysregulation, severe resource limitations in healthcare settings have made COVID-19 units conducive to a variety of secondary infections. Long-term effect of excess antibiotic use in COVID-19patients is yet to be studied. Very few studies have assessed secondary infections as the primary outcome measure making it difficult to know the true incidence. Mortality attributable to secondary infections in COVID-19patients is also unclear. SUMMARY: Incidence of secondary infections in COVID-19patients is likely higher than what is reported in the literature. Well designed studies are needed to understand the incidence and impact of secondary infections in this patient population. Many of these may be preventable especially now, as personal protective equipment and other healthcare resources are recovering. Infection prevention and control (IPC) and antimicrobial stewardship programmes (ASP) must reassess current situation to correct any breaches that could potentially cause more harm in these already vulnerable patients as we brace for a future surge with another pandemic wave.
Authors: Amir Arastehfar; Nevzat Ünal; Tuğrul Hoşbul; Muhammed Alper Özarslan; Ayşe Sultan Karakoyun; Furkan Polat; Diego Fuentes; Ramazan Gümral; Tuba Turunç; Farnaz Daneshnia; David S Perlin; Cornelia Lass-Flörl; Toni Gabaldón; Macit Ilkit; M Hong Nguyen Journal: Open Forum Infect Dis Date: 2022-02-13 Impact factor: 3.835
Authors: Martin Zacharias; Karl Kashofer; Philipp Wurm; Peter Regitnig; Moritz Schütte; Margit Neger; Sandra Ehmann; Leigh M Marsh; Grazyna Kwapiszewska; Martina Loibner; Anna Birnhuber; Eva Leitner; Andrea Thüringer; Elke Winter; Stefan Sauer; Marion J Pollheimer; Fotini R Vagena; Carolin Lackner; Barbara Jelusic; Lesley Ogilvie; Marija Durdevic; Bernd Timmermann; Hans Lehrach; Kurt Zatloukal; Gregor Gorkiewicz Journal: iScience Date: 2022-08-13
Authors: Marco Ripa; Laura Galli; Armando D'Angelo; Luca Apruzzi; Diego Palumbo; Corrado Campochiaro; Chiara Tassan Din; Anna Danise; Valentina Da Prat; Giordano Vitali; Luigia Brugliera; Andrea Poli; Roberta Monardo; Giacomo Monti; Domenico Baccellieri; Francesco De Cobelli; Massimo Clementi; Sandro Iannaccone; Lorenzo Dagna; Patrizia Rovere-Querini; Fabio Ciceri; Moreno Tresoldi; Alberto Zangrillo; Paolo Scarpellini; Antonella Castagna Journal: Open Forum Infect Dis Date: 2022-09-02 Impact factor: 4.423